These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 27212693)

  • 1. Is a one-year follow-up an efficient method for better management of MRI BI-RADS(®) 3 lesions?
    Boisserie-Lacroix M; Ziadé C; Hurtevent-Labrot G; Ferron S; Brouste V; Lippa N
    Breast; 2016 Jun; 27():1-7. PubMed ID: 27212693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BI-RADS® 3 lesions at contrast-enhanced breast MRI: is an initial short-interval follow-up necessary?
    Bahrs SD; Baur A; Hattermann V; Hahn M; Vogel U; Claussen CD; Siegmann-Luz KC
    Acta Radiol; 2014 Apr; 55(3):260-5. PubMed ID: 23969262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging of the breast as a problem-solving method: to be or not to be?
    Oztekin PS; Kosar PN
    Breast J; 2014; 20(6):622-31. PubMed ID: 25200378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics, Malignancy Rate, and Follow-up of BI-RADS Category 3 Lesions Identified at Breast MR Imaging: Implications for MR Image Interpretation and Management.
    Chikarmane SA; Birdwell RL; Poole PS; Sippo DA; Giess CS
    Radiology; 2016 Sep; 280(3):707-15. PubMed ID: 27089027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast-enhanced MR imaging in patients with BI-RADS 3-5 microcalcifications.
    Cilotti A; Iacconi C; Marini C; Moretti M; Mazzotta D; Traino C; Naccarato AG; Piagneri V; Giaconi C; Bevilacqua G; Bartolozzi C
    Radiol Med; 2007 Mar; 112(2):272-86. PubMed ID: 17361370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics and Outcomes of BI-RADS 3 Lesions on Breast MRI.
    Panigrahi B; Harvey SC; Mullen LA; Falomo E; Di Carlo P; Lee B; Myers KS
    Clin Breast Cancer; 2019 Feb; 19(1):e152-e159. PubMed ID: 30268764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BI-RADS 3, 4, and 5 lesions: value of US in management--follow-up and outcome.
    Raza S; Chikarmane SA; Neilsen SS; Zorn LM; Birdwell RL
    Radiology; 2008 Sep; 248(3):773-81. PubMed ID: 18647850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of breast MRI for BI-RADS category 4B mammographic microcalcification: based on the 5
    Eun NL; Son EJ; Gweon HM; Youk JH; Kim JA
    Clin Radiol; 2018 Aug; 73(8):750-755. PubMed ID: 29853301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management for BI-RADS category 3 lesions detected in preoperative breast MR imaging of breast cancer patients.
    Gweon HM; Cho N; Kim SY; Koo HR; Seo M; Chu A; Son EJ
    Eur Radiol; 2017 Aug; 27(8):3211-3216. PubMed ID: 28083693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of probably benign breast MRI lesions.
    Eby PR; DeMartini WB; Gutierrez RL; Saini MH; Peacock S; Lehman CD
    AJR Am J Roentgenol; 2009 Sep; 193(3):861-7. PubMed ID: 19696303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of Malignancy and Imaging Characteristics of Probably Benign Lesions Seen at Breast MRI.
    Grimm LJ; Anderson AL; Baker JA; Johnson KS; Walsh R; Yoon SC; Ghate SV
    AJR Am J Roentgenol; 2015 Aug; 205(2):442-7. PubMed ID: 26204298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient compliance and diagnostic yield of 18-month unilateral follow-up in surveillance of probably benign mammographic lesions.
    Chung CS; Giess CS; Gombos EC; Frost EP; Yeh ED; Raza S; Birdwell RL
    AJR Am J Roentgenol; 2014 Apr; 202(4):922-7. PubMed ID: 24660725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ShearWave™ Elastography BE1 multinational breast study: additional SWE™ features support potential to downgrade BI-RADS®-3 lesions.
    Schäfer FK; Hooley RJ; Ohlinger R; Hahne U; Madjar H; Svensson WE; Balu-Maestro C; Juhan V; Athanasiou A; Mundinger A; Order B; Locatelli M; Cosgrove D; Wolf OJ; Henry JP; Moutfi M; Gay JM; Cohen-Bacrie C
    Ultraschall Med; 2013 Jun; 34(3):254-9. PubMed ID: 23709241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of BI-RADS category 4 lesions detected with screening mammography and screening US: utility of MR imaging.
    Strobel K; Schrading S; Hansen NL; Barabasch A; Kuhl CK
    Radiology; 2015 Feb; 274(2):343-51. PubMed ID: 25271857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The challenge of imaging dense breast parenchyma: is magnetic resonance mammography the technique of choice? A comparative study with x-ray mammography and whole-breast ultrasound.
    Pediconi F; Catalano C; Roselli A; Dominelli V; Cagioli S; Karatasiou A; Pronio A; Kirchin MA; Passariello R
    Invest Radiol; 2009 Jul; 44(7):412-21. PubMed ID: 19448554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reassessment and Follow-Up Results of BI-RADS Category 3 Lesions Detected on Screening Breast Ultrasound.
    Chae EY; Cha JH; Shin HJ; Choi WJ; Kim HH
    AJR Am J Roentgenol; 2016 Mar; 206(3):666-72. PubMed ID: 26901026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of malignancy in palpable solid breast masses considered probably benign or low suspicion: implications for management.
    Giess CS; Smeglin LZ; Meyer JE; Ritner JA; Birdwell RL
    J Ultrasound Med; 2012 Dec; 31(12):1943-9. PubMed ID: 23197547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast MRI as an adjunct to mammography: Does it really suffer from low specificity? A retrospective analysis stratified by mammographic BI-RADS classes.
    Benndorf M; Baltzer PA; Vag T; Gajda M; Runnebaum IB; Kaiser WA
    Acta Radiol; 2010 Sep; 51(7):715-21. PubMed ID: 20707656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. False-negative rate of combined mammography and ultrasound for women with palpable breast masses.
    Chan CH; Coopey SB; Freer PE; Hughes KS
    Breast Cancer Res Treat; 2015 Oct; 153(3):699-702. PubMed ID: 26341750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening US in patients with mammographically dense breasts: initial experience with Connecticut Public Act 09-41.
    Hooley RJ; Greenberg KL; Stackhouse RM; Geisel JL; Butler RS; Philpotts LE
    Radiology; 2012 Oct; 265(1):59-69. PubMed ID: 22723501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.